ID | Name | Number of studies | |
---|---|---|---|
CL_0009010 | transit amplifying cell | 12 | |
CL_0000000 | cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
UGT2B17 | 5 | 31% ± 10% | 0 | 3 | |
LEFTY1 | 4 | 27% ± 6% | 0 | 1 | |
BUB1B | 3 | 29% ± 7% | 0 | 0 | |
KNL1 | 3 | 40% ± 14% | 0 | 0 | |
MCM10 | 3 | 22% ± 7% | 0 | 0 | |
WDR76 | 3 | 31% ± 8% | 0 | 0 | |
NDC80 | 3 | 24% ± 8% | 0 | 0 | |
DSN1 | 3 | 25% ± 1% | 0 | 0 | |
FANCD2 | 3 | 40% ± 19% | 0 | 0 | |
ZNF367 | 3 | 24% ± 4% | 0 | 0 | |
IQGAP3 | 3 | 25% ± 5% | 0 | 0 | |
CDC25C | 3 | 26% ± 8% | 0 | 0 | |
ARHGAP11A | 3 | 25% ± 5% | 0 | 0 | |
DTL | 3 | 33% ± 15% | 0 | 0 | |
ESCO2 | 3 | 23% ± 5% | 0 | 0 | |
BRIP1 | 3 | 50% ± 27% | 0 | 0 | |
BUB1 | 3 | 23% ± 8% | 0 | 0 | |
CENPE | 3 | 27% ± 7% | 0 | 0 | |
NEMP1 | 3 | 28% ± 17% | 0 | 0 | |
MELK | 3 | 45% ± 17% | 0 | 0 | |
CHEK2 | 3 | 35% ± 11% | 0 | 0 | |
OLFM4 | 6 | 49% ± 28% | 1 | 5 | |
KRTCAP3 | 5 | 25% ± 7% | 1 | 9 | |
CLDN15 | 4 | 28% ± 7% | 1 | 5 | |
CDX1 | 6 | 33% ± 16% | 2 | 6 | |
CDX2 | 5 | 24% ± 8% | 2 | 5 | |
SFN | 6 | 29% ± 14% | 2 | 15 | |
SNORC | 5 | 20% ± 3% | 2 | 6 | |
PPP1R1B | 5 | 42% ± 21% | 2 | 7 | |
SLC39A5 | 5 | 17% ± 1% | 2 | 7 |
GO_0007549 | Biological process | sex-chromosome dosage compensation |
GO_0043278 | Biological process | response to morphine |
GO_0044773 | Biological process | mitotic DNA damage checkpoint signaling |
GO_0042276 | Biological process | error-prone translesion synthesis |
GO_0006273 | Biological process | lagging strand elongation |
GO_0060816 | Biological process | random inactivation of X chromosome |
GO_0008089 | Biological process | anterograde axonal transport |
GO_0070914 | Biological process | UV-damage excision repair |
GO_0051026 | Biological process | chiasma assembly |
GO_0043009 | Biological process | chordate embryonic development |
GO_0006543 | Biological process | glutamine catabolic process |
GO_0006290 | Biological process | pyrimidine dimer repair |
GO_0006301 | Biological process | postreplication repair |
GO_0045010 | Biological process | actin nucleation |
GO_0006996 | Biological process | organelle organization |
GO_0030263 | Biological process | apoptotic chromosome condensation |
GO_0051231 | Biological process | spindle elongation |
GO_0046600 | Biological process | negative regulation of centriole replication |
GO_0007284 | Biological process | spermatogonial cell division |
GO_0051154 | Biological process | negative regulation of striated muscle cell differentiation |
GO_0006265 | Biological process | DNA topological change |
GO_0006278 | Biological process | RNA-templated DNA biosynthetic process |
GO_0035795 | Biological process | negative regulation of mitochondrial membrane permeability |
GO_0002360 | Biological process | T cell lineage commitment |
GO_0040016 | Biological process | embryonic cleavage |
GO_1902975 | Biological process | mitotic DNA replication initiation |
GO_0016446 | Biological process | somatic hypermutation of immunoglobulin genes |
GO_0006266 | Biological process | DNA ligation |
GO_0071681 | Biological process | cellular response to indole-3-methanol |
GO_0043131 | Biological process | erythrocyte enucleation |
Cell type name | transit amplifying cell |
Synonyms | transient amplifying cell transit amplifying progenitor cell transit-amplifying cell |
Description | Transit-amplifying cells (TACs) are an undifferentiated population in transition between stem cells and differentiated cells. |
Parent |